Status:
WITHDRAWN
Autoimmune Diabetes: Markers of the Disease and Treatment of Latent Autoimmune Diabetes in Adults (LADA)
Lead Sponsor:
Norwegian University of Science and Technology
Conditions:
Autoimmune Diabetes
Eligibility:
All Genders
30-75 years
Brief Summary
Autoimmunity is the main cause of diabetes type 1 and an important factor as cause of Latent Autoimmune Diabetes in Adults (LADA). Recently, research has found that being deficient of T-reg cells is a...
Detailed Description
Research has worked out that b-cells are being destroyed by cytokines released from inflammatory cells. One hypothesis in that T-reg is a cause of autoimmunity, and that T-reg concentrations are low i...
Eligibility Criteria
Inclusion
- newly diagnosed diabetes type 1
- LADA
- diabetes type 1 older than 10 years
Exclusion
- none
Key Trial Info
Start Date :
August 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01148238
Start Date
August 1 2012
End Date
December 1 2012
Last Update
December 10 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.